All Stories

  1. Changes in the incidence of seasonal influenza in response to COVID-19 social distancing measures: an observational study based on Canada’s national influenza surveillance system

    Article • October 2020, Research Square

    Dr Yoav Keynan

  2. Short- and Long-term Outcomes of Medically Treated Isolated Left-Sided Endocarditis: A Retrospective Study With 5-Year Longitudinal Follow-up

    Article • Canadian Journal of Cardiology, September 2020, Elsevier

    Dr Yoav Keynan

  3. Molecular detection of Coxiella burnetii in livestock farmers and cattle from Magdalena Medio in Antioquia, Colombia

    Article • PLoS ONE, June 2020, PLOS

    Dr Yoav Keynan

  4. Cohort profile: the LHIV-Manitoba clinical cohort of people living with HIV in Manitoba, Canada

    Article • BMJ Open, May 2020, BMJ

    Dr Yoav Keynan

  5. Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review

    Article • Journal of Immunology Research, April 2020, Hindawi Publishing Corporation

    Dr Yoav Keynan

  6. Pathway mapping of leukocyte transcriptome in influenza patients reveals distinct pathogenic mechanisms associated with progression to severe infection

    Article • BMC Medical Genomics, February 2020, Springer Science + Business Media

    Dr Yoav Keynan

  7. Review of Evidence for Using Chest X-Rays for Active Tuberculosis Screening in Long-Term Care in Canada

    Article • Frontiers in Public Health, February 2020, Frontiers

    Dr Yoav Keynan

  8. Inflammatory Cell Differentiation and Chemotaxis and Extracellular Tissue Repair Markers Are Correlated with Pulmonary Dysfunction in HIV Infected Individuals Presenting with Community-Acquired Pneumonia

    Article • Journal of Interferon & Cytokine Research, February 2020, Mary Ann Liebert Inc

    Dr Yoav Keynan

  9. Secondary syphilis with atypical rash and hemoptysis in a man with HIV co-infection

    Article • Canadian Medical Association Journal, December 2019, Canadian Medical Association (CMA)

    Dr Yoav Keynan

  10. Inflammatory mediators and lung abnormalities in HIV: A systematic review

    Article • PLoS ONE, December 2019, PLOS

    Dr Yoav Keynan, Zulma Rueda

  11. Is tuberculosis elimination a feasible goal in Colombia by 2050?

    Article • Health Policy and Planning, October 2019, Oxford University Press (OUP)

    Dr Yoav Keynan

  12. Clinical utility of echocardiography for the diagnosis of native valve infective endocarditis in Staphylococcus aureus bacteremia

    Article • Echocardiography, September 2019, Wiley

    Dr Yoav Keynan

  13. Legionella co-infection in HIV-associated pneumonia

    Article • Diagnostic Microbiology and Infectious Disease, September 2019, Elsevier

    Dr Yoav Keynan

  14. Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection

    Article • Nature Communications, July 2019, Springer Science + Business Media

    Dr Yoav Keynan

  15. Strengthening tuberculosis surveillance in Canada

    Article • Canadian Medical Association Journal, July 2019, Canadian Medical Association (CMA)

    Dr Yoav Keynan

  16. Homelessness and HIV: A Combination Predictive of Poor Tuberculosis Treatment Outcomes and in Need of Innovative Strategies to Improve Treatment Completion

    Article • American Journal of Tropical Medicine and Hygiene, April 2019, American Society of Tropical Medicine and Hygiene

    Dr Yoav Keynan

  17. Integrated Care for Latent Tuberculosis Infection (LTBI) at a Primary Health Care Facility for Refugees in Winnipeg, Canada: A Mixed-Methods Evaluation

    Article • Frontiers in Public Health, March 2019, Frontiers

    Dr Yoav Keynan

  18. Looking for Evidence of Public Health's Role for Long-Term Evacuees

    Article • Frontiers in Public Health, February 2019, Frontiers

    Dr Yoav Keynan

  19. A Dene First Nation’s community readiness assessment to take action against HIV/AIDS: a pilot project

    Article • International Journal of Circumpolar Health, January 2019, Taylor & Francis

    Yoav Keynan, Dr Yoav Keynan

  20. Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV-Infected Individuals

    Article • HIV Medicine, October 2018, Wiley

    Dr Yoav Keynan

  21. Similar Outcomes ofLegionellaPneumonia in Treated Human Immunodeficiency Virus Infection

    Article • Clinical Infectious Diseases, October 2018, Oxford University Press (OUP)

    Dr Yoav Keynan

  22. Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings

    Article • Antimicrobial Resistance and Infection Control, August 2018, Springer Science + Business Media

    Dr Yoav Keynan

  23. Guards in Prisons: A Risk Group for Latent Tuberculosis Infection

    Article • Journal of Immigrant and Minority Health, May 2018, Springer Science + Business Media

    Dr Yoav Keynan

  24. The value of program science to optimize knowledge brokering on infectious diseases for public health

    Article • BMC Public Health, May 2018, Springer Science + Business Media

    Dr Yoav Keynan

  25. Funding for Antimicrobial Stewardship Programs: A Customizable Business Case Template

    Article • The Canadian Journal of Hospital Pharmacy, March 2018, Canadian Society of Hospital Pharmacists (CSHP)

    Dr Yoav Keynan

  26. Dolutegravir with boosted darunavir treatment simplification for the transmitted HIV thymidine analog resistance in Manitoba, Canada

    Article • International Journal of STD & AIDS, March 2018, SAGE Publications

    Yoav Keynan, Dr Yoav Keynan

  27. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression

    Article • Journal of Infection and Public Health, March 2018, Elsevier

    Dr Yoav Keynan

  28. Central nervous system blastomycosis diagnosed using the MVista® Blastomyces quantitative antigen enzyme immunoassay test on cerebrospinal fluid: A case report and review of the literature

    Article • Diagnostic Microbiology and Infectious Disease, February 2018, Elsevier

    Dr Yoav Keynan

  29. Emerging group C and group G streptococcal endocarditis: A Canadian perspective

    Article • International Journal of Infectious Diseases, December 2017, Elsevier

    Dr Yoav Keynan

  30. Atypical bacterial pneumonia in the HIV-infected population

    Article • Pneumonia, August 2017, Springer Science + Business Media

    Dr Yoav Keynan

  31. HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery

    Article • Scientific Reports, August 2017, Springer Science + Business Media

    Dr Yoav Keynan

  32. Negative latent tuberculosis at time of incarceration: identifying a very high-risk group for infection

    Article • Epidemiology and Infection, July 2017, Cambridge University Press

    Zulma Rueda, Dr Yoav Keynan

  33. Clonal Clusters and Virulence Factors of Group C and GStreptococcusCausing Severe Infections, Manitoba, Canada, 2012–2014

    Article • Emerging Infectious Diseases, July 2017, Centers for Disease Control and Prevention (CDC)

    Dr Yoav Keynan

  34. Characteristics of hospital admissions for pneumonia in HIV-positive individuals in Winnipeg, Manitoba: a cross-sectional retrospective analysis

    Article • International Journal of STD & AIDS, June 2017, SAGE Publications

    Yoav Keynan, Dr Yoav Keynan

  35. A novel immune biomarkerIFI27discriminates between influenza and bacteria in patients with suspected respiratory infection

    Article • European Respiratory Journal, June 2017, European Respiratory Society (ERS)

    Dr Yoav Keynan

  36. Systemic inflammation before and after antiretroviral therapy initiation as a predictor of immune response among HIV-infected individuals in Manitoba

    Article • Cytokine, March 2017, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  37. Immune Reconstitution Syndrome secondary to Rhodococcus equi infection in a patient with HIV and Burkitt's lymphoma

    Article • Journal of Infection and Public Health, March 2017, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  38. Lymphadenopathy

    Article • January 2017, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  39. Evaluation and Management of the Solitary Enlarged Lymph Node

    Article • January 2017, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  40. Evaluation of the Utility of Point-of-Care HIV Testing on a Canadian Internal Medicine Inpatient Unit

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2017, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  41. Analysis of Short- and Long-term Outcomes of Patients With Surgically Treated Left-sided Infective Endocarditis: A 5-Year Longitudinal Follow-up Study

    Article • Seminars in Thoracic and Cardiovascular Surgery, January 2017, Elsevier

    Dr Yoav Keynan

  42. Snowshoe Hare Virus Causing Meningoencephalitis in a Young Adult From Northern Manitoba, Canada

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Dr Yoav Keynan

  43. The Prevalence of Legionella Species as a Co-pathogen in HIV-Associated Community-Acquired Pneumonia

    Article • Open Forum Infectious Diseases, January 2017, Oxford University Press (OUP)

    Dr Yoav Keynan

  44. Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis

    Article • Journal of Antimicrobial Chemotherapy, December 2016, Oxford University Press (OUP)

    Yoav Keynan, Dr Yoav Keynan

  45. A case of tetanus secondary to an odontogenic infection

    Article • Canadian Journal of Emergency Medicine, December 2016, Cambridge University Press

    Yoav Keynan, Dr Yoav Keynan

  46. Alternative Cardiac Imaging Modalities to Echocardiography for the Diagnosis of Infective Endocarditis

    Article • The American Journal of Cardiology, November 2016, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  47. War Trauma, Politics of Recognition and Purple Heart: PTSD or PTSI?

    Article • Social Sciences, September 2016, MDPI AG

    Dr Yoav Keynan

  48. Inflammatory cytokine and gene expression patterns correlate with etiologic agent causing pneumonia among patients with advanced HIV in Medellin, Colombia

    Article • Journal of Clinical Virology, September 2016, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  49. Prior history of testing for syphilis, hepatitis B and hepatitis C among a population-based cohort of HIV-positive individuals and their HIV-negative controls

    Article • AIDS Care, June 2016, Taylor & Francis

    Yoav Keynan, Dr Yoav Keynan

  50. Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults

    Article • Vaccine, June 2016, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  51. Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis

    Article • Journal of the American Heart Association, April 2016, Wolters Kluwer Health

    Dr Yoav Keynan, Christine Selton-Suty

  52. Utilization of Echocardiography in Patients With Staphylococcus aureus Bacteremia at Two Large Canadian Hospitals

    Article • Infectious Diseases in Clinical Practice, March 2016, Wolters Kluwer Health

    Yoav Keynan, Dr Yoav Keynan

  53. Quintessential Culture-Negative Endocarditis

    Article • Canadian Journal of Cardiology, March 2016, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  54. Blood Culture Negative Endocarditis

    Article • January 2016, Springer Science + Business Media

    Yoav Keynan, Dr Yoav Keynan

  55. Changing Populations: The Elderly, Injection Drug Users, Health-Care Associated Endocarditis and Immunocompromised Patients

    Article • January 2016, Springer Science + Business Media

    Yoav Keynan, Dr Yoav Keynan

  56. Group C and G Streptococci: An Emerging Cause of Endocarditis and Severe Infections in Manitoba, Canada

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    Yoav Keynan, Dr Yoav Keynan

  57. HLA B51 is associated with faster AIDS progression among newly diagnosed HIV-infected individuals in Manitoba, Canada

    Article • International Journal of Immunogenetics, August 2015, Wiley

    Dr Yoav Keynan

  58. Unique cytokine and chemokine patterns in bronchoalveolar lavage are associated with specific causative pathogen among HIV infected patients with pneumonia, in Medellin, Colombia

    Article • Cytokine, June 2015, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  59. Substance use and its impact on care outcomes among HIV-infected individuals in Manitoba

    Article • AIDS Care, May 2015, Taylor & Francis

    Yoav Keynan, Dr Yoav Keynan

  60. Rapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada

    Article • Infectious Diseases, March 2015, Informa Healthcare

    Yoav Keynan, Dr Yoav Keynan

  61. Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy

    Article • Antimicrobial Agents and Chemotherapy, February 2015, ASM Journals

    Dr Yoav Keynan

  62. Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis

    Article • Circulation, January 2015, Wolters Kluwer Health

    Dr Yoav Keynan

  63. One-year outcome following biological or mechanical valve replacement for infective endocarditis

    Article • International Journal of Cardiology, January 2015, Elsevier

    Christine Selton-Suty, Dr Yoav Keynan

  64. Relapse of Visceral Leishmaniasis in an HIV-Infected Patient Successfully Treated with a Combination of Miltefosine and Amphotericin B

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2015, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  65. Vitamin D binding protein polymorphism protects against development of blastomycosis

    Article • Journal de Mycologie Médicale, December 2014, Elsevier

    Dr Yoav Keynan

  66. Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of Endocarditis–Prospective Cohort Study

    Article • Clinical Infectious Diseases, November 2014, Oxford University Press (OUP)

    Dr Yoav Keynan, Christine Selton-Suty

  67. Changing trends in β-hemolytic streptococcal bacteremia in Manitoba, Canada: 2007–2012

    Article • International Journal of Infectious Diseases, November 2014, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  68. Vancomycin Revisited – 60 Years Later

    Article • Frontiers in Public Health, October 2014, Frontiers

    Yoav Keynan, Dr Yoav Keynan

  69. High prevalence and risk factors associated with latent tuberculous infection in two Colombian prisons

    Article • The International Journal of Tuberculosis and Lung Disease, October 2014, International Union Against Tuberculosis and Lung Disease

    Dr Yoav Keynan

  70. Comparison between transthoracic and transesophageal echocardiography in screening for infective endocarditis in patients with Staphylococcus aureus bacteremia

    Article • European Journal of Clinical Microbiology & Infectious Diseases, June 2014, Springer Science + Business Media

    Dr Yoav Keynan

  71. Hypermucoviscous Klebsiella Syndrome Without Liver Abscess in a Patient With Immunoglobulin G2 Immune Deficiency

    Article • Open Forum Infectious Diseases, January 2014, Oxford University Press (OUP)

    Yoav Keynan, Dr Yoav Keynan

  72. Letter to the Editor

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2014, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  73. Vancomycin-Resistant Enterococci

    Article • Critical Care Clinics, October 2013, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  74. Infective Endocarditis in the Intensive Care Unit

    Article • Critical Care Clinics, October 2013, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  75. Quinolones for mycobacterial infections

    Article • International Journal of Antimicrobial Agents, July 2013, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  76. Staphylococcus aureus Bacteremia, Risk Factors, Complications, and Management

    Article • Critical Care Clinics, July 2013, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  77. Pathophysiology of Infective Endocarditis

    Article • Current Infectious Disease Reports, June 2013, Springer Science + Business Media

    Yoav Keynan, Dr Yoav Keynan

  78. Short-course therapy for severe infections

    Article • International Journal of Antimicrobial Agents, June 2013, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  79. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort

    Article • PLoS ONE, May 2013, PLOS

    Dr Yoav Keynan, Christine Selton-Suty

  80. Diarrhea and Colonic Ulcers of Unusual Etiology

    Article • Mycobacterial Diseases, January 2013, OMICS Publishing Group

    Yoav Keynan, Dr Yoav Keynan

  81. Feasibility and Success of Hiv Point-of-Care Testing in an Emergency Department in an Urban Canadian Setting

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2013, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  82. The Role of Polymorphisms in Host Immune Genes in Determining the Severity of Respiratory Illness Caused by Pandemic H1N1 Influenza

    Article • Public Health Genomics, January 2013, Karger Publishers

    Dr Yoav Keynan

  83. Legionella pneumophilaSerotype 1 Pneumonia in Patient Receiving Adalimumab

    Article • Emerging Infectious Diseases, November 2012, Centers for Disease Control and Prevention (CDC)

    Yoav Keynan, Dr Yoav Keynan

  84. Influence of the Timing of Cardiac Surgery on the Outcome of Patients With Infective Endocarditis and Stroke

    Article • Clinical Infectious Diseases, October 2012, Oxford University Press (OUP)

    Dr Yoav Keynan, Christine Selton-Suty

  85. Invariant NKT Cells: Regulation and Function during Viral Infection

    Article • PLoS Pathogens, August 2012, PLOS

    Yoav Keynan, Dr Yoav Keynan

  86. The microbiology of endophthalmitis: global trends and a local perspective

    Article • European Journal of Clinical Microbiology & Infectious Diseases, June 2012, Springer Science + Business Media

    Dr Yoav Keynan

  87. HIV Controllers Are Distinguished by Chemokine Expression Profile and HIV-Specific T-Cell Proliferative Potential

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, April 2012, Wolters Kluwer Health

    Yoav Keynan, Dr Yoav Keynan

  88. Medical ward admissions among HIV-positive patients in Winnipeg, Canada, 2003–10

    Article • International Journal of STD & AIDS, April 2012, SAGE Publications

    Dr Yoav Keynan

  89. Predictors of Serological Cure After Treatment of Early Syphilis

    Article • Clinical Infectious Diseases, February 2012, Oxford University Press (OUP)

    Yoav Keynan, Dr Yoav Keynan

  90. Altered dendritic cell–natural killer interaction in Kenyan sex workers resistant to HIV-1 infection

    Article • AIDS, February 2012, Wolters Kluwer Health

    Yoav Keynan, Dr Yoav Keynan

  91. Genetic Polymorphisms and Drug Susceptibility in Four Isolates of Leishmania tropica Obtained from Canadian Soldiers Returning from Afghanistan

    Article • PLoS Neglected Tropical Diseases, January 2012, PLOS

    Yoav Keynan, Dr Yoav Keynan

  92. Maraviroc Induced CCR5 Blockage for HIV Infected Individuals is Associated with Increased Rates of Respiratory Tract Infections

    Article • Virology & Mycology, January 2012, OMICS Publishing Group

    Yoav Keynan, Dr Yoav Keynan

  93. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals

    Article • BMC Immunology, January 2012, Springer Science + Business Media

    Yoav Keynan, Dr Yoav Keynan

  94. Immunogenetic Factors Associated with Severe Respiratory Illness Caused by Zoonotic H1N1 and H5N1 Influenza Viruses

    Article • Developmental Immunology, January 2012, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  95. Serological Survey of the Novel Influenza A H1N1 in Inner City Winnipeg, Manitoba, 2009

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2012, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  96. Multiloculated Liver Abscess

    Article • Clinical Infectious Diseases, December 2011, Oxford University Press (OUP)

    Yoav Keynan, Dr Yoav Keynan

  97. Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 2011, Springer Science + Business Media

    Dr Yoav Keynan

  98. Targeting the Chemokine Receptor CCR5: Good for HIV, What about Other Viruses?

    Article • The Journal of Infectious Diseases, January 2011, Oxford University Press (OUP)

    Yoav Keynan, Dr Yoav Keynan

  99. Evaluation of Influenza-Specific Humoral Response by Microbead Array Analysis

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2011, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  100. Toll-Like Receptors Dysregulation after Influenza Virus Infection: Insights into Pathogenesis of Subsequent Bacterial Pneumonia

    Article • ISRN Pulmonology, January 2011, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  101. Chemokine Receptor 5 Δ32 Allele in Patients with Severe Pandemic (H1N1) 2009

    Article • Emerging Infectious Diseases, October 2010, Centers for Disease Control and Prevention (CDC)

    Yoav Keynan, Dr Yoav Keynan

  102. Estimated cumulative incidence of pandemic (H1N1) influenza among pregnant women during the first wave of the 2009 pandemic

    Article • Canadian Medical Association Journal, September 2010, Canadian Medical Association (CMA)

    Dr Yoav Keynan

  103. Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross-reactivity to other strains

    Article • Clinical Microbiology and Infection, August 2010, Elsevier

    Dr Yoav Keynan

  104. Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross reactivity to other strains.

    Article • Clinical Microbiology and Infection, December 2009, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  105. Are drug clinical trials broadly applicable? The case of staphylococcal bacteraemia

    Article • International Journal of Antimicrobial Agents, January 2009, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  106. Endogenous endophthalmitis caused by hypermucoviscous Klebsiella pneumoniae: An emerging disease in Southeast Asia and Beyond

    Article • Current Infectious Disease Reports, September 2008, Springer Science + Business Media

    Yoav Keynan, Dr Yoav Keynan

  107. Capsular Polysaccharide Synthesis Regions in Klebsiella pneumoniae Serotype K57 and a New Capsular Serotype

    Article • Journal of Clinical Microbiology, May 2008, ASM Journals

    Dr Yoav Keynan

  108. The Role of Regulatory T Cells in Chronic and Acute Viral Infections

    Article • Clinical Infectious Diseases, April 2008, Oxford University Press (OUP)

    Yoav Keynan, Dr Yoav Keynan

  109. Use of Oral Miltefosine for Cutaneous Leishmaniasis in Canadian Soldiers Returning from Afghanistan

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2008, Hindawi Publishing Corporation

    Yoav Keynan, Dr Yoav Keynan

  110. The changing face of Klebsiella pneumoniae infections in the community

    Article • International Journal of Antimicrobial Agents, November 2007, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  111. Acremonium Vertebral Osteomyelitis: Molecular Diagnosis and Response to Voriconazole

    Article • Clinical Infectious Diseases, July 2007, Oxford University Press (OUP)

    Dr Yoav Keynan

  112. Fungal endocarditis

    Article • Current Fungal Infection Reports, June 2007, Springer Science + Business Media

    Yoav Keynan, Dr Yoav Keynan

  113. Molecular identification of Exiguobacterium acetylicum as the aetiological agent of bacteraemia

    Article • Journal of Medical Microbiology, April 2007, Society for General Microbiology

    Dr Yoav Keynan

  114. Hyperbaric oxygen in the treatment of sudden deafness

    Article • European Archives of Oto-Rhino-Laryngology, March 2007, Springer Science + Business Media

    Yoav Keynan, Dr Yoav Keynan

  115. Pulmonary Nocardia nova infection

    Article • European Journal of Internal Medicine, March 2007, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  116. Pyogenic liver abscess caused by hypermucoviscous Klebsiella pneumoniae

    Article • Scandinavian Journal of Infectious Diseases, January 2007, Taylor & Francis

    Yoav Keynan, Dr Yoav Keynan

  117. Bone marrow and skin granulomatosis in a patient with Bartonella infection

    Article • Journal of Medical Microbiology, January 2007, Society for General Microbiology

    Dr Yoav Keynan

  118. RESPIRATORY MUSCLE TRAINING IN OXYGEN DIVERS: REDUCED DYSPNEA AND INCREASED ENDURANCE

    Article • CHEST Journal, October 2006, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  119. Identification of Two Novel HLA-C Alleles, Cw*070105 and Cw*1408, from East African Women

    Article • Human Immunology, April 2006, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  120. Hyperbaric therapy for bilateral visual loss during hemodialysis

    Article • Clinical and Experimental Nephrology, March 2006, Springer Science + Business Media

    Yoav Keynan, Dr Yoav Keynan

  121. Hypoxia–reoxygenation contributes to increased frequency of venous thromboembolism in air travellers

    Article • Medical Hypotheses, January 2006, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  122. Hyperbaric Oxygen in the Treatment of Carbon Monoxide Poisoning

    Article • Journal of Toxicology Clinical Toxicology, April 2005, Taylor & Francis

    Yoav Keynan, Dr Yoav Keynan

  123. Underwater Hearing and Sound Localization with and without an Air Interface

    Article • Otology & Neurotology, January 2005, Wolters Kluwer Health

    Yoav Keynan, Dr Yoav Keynan

  124. Hyperbaric Oxygen in the Treatment of Carbon Monoxide Poisoning

    Article • Journal of Toxicology Clinical Toxicology, January 2005, Taylor & Francis

    Yoav Keynan, Dr Yoav Keynan

  125. Swimming-Induced Pulmonary Edema

    Article • CHEST Journal, August 2004, Elsevier

    Yoav Keynan, Dr Yoav Keynan

  126. Neurological symptoms in a traveller returning from Central America

    Article • Journal of Internal Medicine, August 2004, Wiley

    Dr Yoav Keynan

  127. The Impact of Solvent Use Amongst HIV + Individuals in Manitoba

    Article • American Psychological Association (APA)

    Yoav Keynan, Dr Yoav Keynan